Aethlon Medical, Inc. (AEMD)

$ 5.27
-0.27 (-4.87%)
Neutral
Symbol AEMD
Price $ 5.27
Beta 0.563
Volume Avg. 5.12M
Market Cap 0.06B
Shares () -
52 Week Range 1.22-12.49
1y Target Est -
DCF Unlevered -
DCF Levered -
ROE -59.89% Strong Sell
ROA -58.46% Strong Sell
Operating Margin -
Debt / Equity 10.81% Neutral
P/E -
P/B 5.57 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasd...

SAN DIEGO, June 10, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), a medical device technology company focused on unmet needs in global health, today announced that it has entered into a definitive agreement with a single institutional inv... ...

PRNewsWire
AEMD Stock Price: 388.24% Increase Explanation

AEMD Stock Price: 388.24% Increase Explanation

The stock price of Aethlon Medical, Inc. (NASDAQ: AEMD) increased 388.24% yesterday. This is why it happened. ...

Pulse2
AEMD, CTEK, AEHL, AMSWA, CKPT, CLNE, SPI, ATOM, PUBM, IMH Stock Prices Gain Intraday

AEMD, CTEK, AEHL, AMSWA, CKPT, CLNE, SPI, ATOM, PUBM, IMH Stock Prices Gain Intraday

The stock prices of AEMD, CTEK, AEHL, AMSWA, CKPT, CLNE, SPI, ATOM, PUBM, and IMH have noticeably gained today. The post AEMD, CTEK, AEHL, AMSWA, CKPT, CLNE, SPI, ATOM, PUBM, IMH Stock Prices Gain Intraday appeared first on Pulse 2.0. ...

Pulse2
Aethlon Medical stock explodes 465% on heavy volume as new report about COVID-19 treatment inspires social-media discussion (AEMD)

Aethlon Medical stock explodes 465% on heavy volume as new report about COVID-19 treatment inspires ...

Shares of Aethlon Medical exploded as much as 465% to a two-year high on Wednesday despite not releasing any news since last week, when one of its devices showed positive results in two COVID-19 patients. A June 8 report from Zacks Investment Researc... ...

Business Insider
AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 350%+

AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 350%+

Shares of AEMD stock are taking off on Wednesday following the firm's June 3 report of its coronavirus treatment returning promising results. The post AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 350%+ appeared first on In... ...

InvestorPlace
Aethlon Medical stock more than quadruples on heavy volume

Aethlon Medical stock more than quadruples on heavy volume

Shares of Aethlon Medical Inc. skyrocketed more than fourfold on massive volume toward a two-year high in morning trading Wednesday, even though the California-based therapeutic technology company hasn't released any news in nearly a week. On June 3,... ...

Market Watch
AEMD Stock Price: Over 290% Increase Pre-Market Explanation

AEMD Stock Price: Over 290% Increase Pre-Market Explanation

The stock price of Aethlon Medical, Inc. (NASDAQ: AEMD) increased by over 290% pre-market today. This is why it happened. ...

Pulse2
Why Aethlon Medical Stock Skyrocketing?

Why Aethlon Medical Stock Skyrocketing?

Aethlon Medical Inc (NASDAQ: AEMD) stock surged probably in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An Infected Patient.' The company recently announced the positive results from using its Hemopu... ...

Benzinga
Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemo...

SAN DIEGO, June 3, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced the publication of a pre-print manuscript highlighting two case studies of crit... ...

PRNewsWire
Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

SAN DIEGO, March 1, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that the company will participate in the H.C. Wainwright Global Life Sciences ...

PRNewsWire

About


Dr. Timothy Rodell
Healthcare
Medical Devices
Nasdaq Capital Market

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. The company is headquartered in San Diego, California and currently employs 6 full-time employees. The firm operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The firm's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.